GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Penumbra Inc (MEX:PEN) » Definitions » EV-to-FCF

Penumbra (MEX:PEN) EV-to-FCF : 73.17 (As of Mar. 30, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Penumbra EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Penumbra's Enterprise Value is MXN206,951 Mil. Penumbra's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was MXN2,828 Mil. Therefore, Penumbra's EV-to-FCF for today is 73.17.

The historical rank and industry rank for Penumbra's EV-to-FCF or its related term are showing as below:

MEX:PEN' s EV-to-FCF Range Over the Past 10 Years
Min: -69927.64   Med: -81.41   Max: 26466.1
Current: 69.17

During the past 13 years, the highest EV-to-FCF of Penumbra was 26466.10. The lowest was -69927.64. And the median was -81.41.

MEX:PEN's EV-to-FCF is ranked worse than
81.51% of 384 companies
in the Medical Devices & Instruments industry
Industry Median: 26.5 vs MEX:PEN: 69.17

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-30), Penumbra's stock price is MXN4911.82. Penumbra's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was MXN8.615. Therefore, Penumbra's PE Ratio (TTM) for today is 570.15.


Penumbra EV-to-FCF Historical Data

The historical data trend for Penumbra's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Penumbra EV-to-FCF Chart

Penumbra Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -106.58 -917.59 -113.73 117.82 61.26

Penumbra Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.82 81.32 62.15 55.08 61.26

Competitive Comparison of Penumbra's EV-to-FCF

For the Medical Devices subindustry, Penumbra's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Penumbra's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Penumbra's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Penumbra's EV-to-FCF falls into.


;
;

Penumbra EV-to-FCF Calculation

Penumbra's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=206950.545/2828.43
=73.17

Penumbra's current Enterprise Value is MXN206,951 Mil.
Penumbra's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN2,828 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Penumbra  (MEX:PEN) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Penumbra's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4911.82/8.615
=570.15

Penumbra's share price for today is MXN4911.82.
Penumbra's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN8.615.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Penumbra EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Penumbra's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Penumbra Business Description

Traded in Other Exchanges
Address
One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.